Interactive Data Dashboards
Live indicators, province breakdowns and downloadable data.
Special youth clinics appear to be an effective means of providing healthcare services to young people who otherwise might not engage with healthcare services. But is building more youth clinics realistic given our resource constraints, or is it better to focus on making ‘normal’ clinics more youth-friendly – or should we be looking beyond clinic-based…
·
The community-led clinic monitoring project, Ritshidze last week, released its follow-up report on the state of (primary) healthcare in Mpumalanga. There were some improvements, but patients are still waiting over four hours to be seen at some clinics. Nthusang Lefafa unpacks some of the report’s findings and asked the health department about its plans to…
·
In 2019, the Department of Health started providing the antiretroviral drug dolutegravir as part of HIV treatment in the public sector. Three years later, close to 3.2 million people in South Africa are taking dolutegravir every day. Even so, the rollout of dolutegravir hasn’t all been smooth sailing. Elri Voigt investigates how the massive undertaking…
·
The National Department of Health says that lubricant should be freely available alongside condoms at clinics around the country. But according to community-led monitoring group Ritshidze, clinics often do not offer lubricant. Biénne Huisman reports on why access to lubricant is important for HIV prevention and why oil-based lubricants should not be used with condoms.
·
South Africa’s new National Strategic Plan for HIV, TB, and STIs is being developed this year. Spotlight editor Marcus Low asks what we should aim for in the new strategy and how we should go about developing it.
·
Cryptococcal meningitis is the second top killer of people living with HIV in South Africa. In the second of a two-part series on access to treatment for the condition, Catherine Tomlinson puts the Spotlight on the drug liposomal amphotericin B (part one looked at flucytosine).
·
The South African Health Products Regulatory Authority recently approved the use of the monthly dapivirine vaginal ring for women 18 years and older to reduce the risk of HIV infection. Thabo Molelekwa looks at the evidence for the ring’s efficacy and asks what plans there are for making it available to women in South Africa.
·
Broadly neutralising antibodies (bnAbs) are one of the most active and exciting areas in HIV research. Last year Spotlight reported on a “proof of concept” study showing that a specific bnAb can successfully prevent infection with certain strains of HIV. Now, we also have intriguing findings suggesting that bnAbs may have a role to play…
·
HIV and ageing were one of the hot topics at the recently held Conference on Retroviruses and Opportunistic Infections. Elri Voigt reports.
·
Even though the rate of new HIV infections in young women and adolescent girls remains stubbornly high, provision and uptake of pills that can prevent HIV infection have generally been slow and lagging. One potential solution presented at the recent Conference on Retroviruses and Opportunistic Infections is to provide the pills at schools. Tiyese Jeranji…
·
An HIV prevention injection taken every two months was recently approved in the United States. Several HIV activists interviewed by Thabo Molelekwa say that access to the injection should be prioritised in South Africa and that we need to do a better job in rolling out the injection than we did with the rollout of…
·
There is no time to waste in planning the South African rollout of cabotegravir (CAB LA), the long-lasting antiretroviral injection approved for use in the United States in December 2021, say local health experts.
·
